{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "FRET substrate",
      "SARS-CoV-2",
      "biochemical protease assay",
      "main protease"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34151620",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/24725552211020681"
    ],
    "Journal": {
      "ISSN": "2472-5560",
      "JournalIssue": {
        "Volume": "26",
        "Issue": "9",
        "PubDate": {
          "Year": "2021",
          "Month": "Oct"
        }
      },
      "Title": "SLAS discovery : advancing life sciences R & D",
      "ISOAbbreviation": "SLAS Discov"
    },
    "ArticleTitle": "Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay.",
    "Pagination": {
      "StartPage": "1189",
      "EndPage": "1199",
      "MedlinePgn": "1189-1199"
    },
    "Abstract": {
      "AbstractText": [
        "The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has a huge impact on the world. Although several vaccines have recently reached the market, the development of specific antiviral drugs against SARS-CoV-2 is an important additional strategy in fighting the pandemic. One of the most promising pharmacological targets is the viral main protease (M<sup>pro</sup>). Here, we present an optimized biochemical assay procedure for SARS-CoV-2 M<sup>pro</sup>. We have comprehensively investigated the influence of different buffer components and conditions on the assay performance and characterized F\u00f6rster resonance energy transfer (FRET) substrates with a preference for 2-Abz/Tyr(3-NO<sub>2</sub>) FRET pairs. The substrates 2-AbzSAVLQSGTyr(3-NO<sub>2</sub>)R-OH, a truncated version of the established DABCYL/EDANS FRET substrate, and 2-AbzVVTLQSGTyr(3-NO<sub>2</sub>)R-OH are promising candidates for screening and inhibitor characterization. In the latter substrate, the incorporation of Val at position P5 improved the catalytic efficiency. Based on the obtained results, we present here a reproducible, reliable assay protocol using highly affordable buffer components."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany."
          }
        ],
        "LastName": "Dra\u017ei\u0107",
        "ForeName": "Tonko",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0001-9025-7245"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany."
          }
        ],
        "LastName": "K\u00fchl",
        "ForeName": "Nikos",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany."
          }
        ],
        "LastName": "Leuthold",
        "ForeName": "Mila M",
        "Initials": "MM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany."
          }
        ],
        "LastName": "Behnam",
        "ForeName": "Mira A M",
        "Initials": "MAM"
      },
      {
        "Identifier": [
          "0000-0003-3522-9182"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany."
          }
        ],
        "LastName": "Klein",
        "ForeName": "Christian D",
        "Initials": "CD"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "SLAS Discov",
    "NlmUniqueID": "101697563",
    "ISSNLinking": "2472-5552"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Protease Inhibitors"
    },
    {
      "RegistryNumber": "EC 3.4.-",
      "NameOfSubstance": "Peptide Hydrolases"
    },
    {
      "RegistryNumber": "EC 3.4.22.-",
      "NameOfSubstance": "Cysteine Endopeptidases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "isolation & purification",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biological Assay"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cysteine Endopeptidases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Discovery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fluorescence Resonance Energy Transfer"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Docking Simulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "Peptide Hydrolases"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "therapeutic use"
      ],
      "DescriptorName": "Protease Inhibitors"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}